COL1A2 and pancreatic neoplasm: Wu et al. Wu et al. (2019a) reduced the expression of COL1A2 to reduce the invasion and migration ability of pancreatic cancer cells and found that COL1A2 was highly expressed in pancreatic cancer patients (p < 0.05), which was related to poor prognosis in these patients.